Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yiao Tan"'
Autor:
Youguang Pu, Yiao Tan, Chunbao Zang, Fangfang Zhao, Cifeng Cai, Lingsuo Kong, Hui Deng, Fengmei Chao, Ran Xia, Minghua Xie, Fangfang Ge, Yueyin Pan, Shanbao Cai, Dabing Huang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 12, Pp 1-15 (2021)
Abstract Long-noncoding RNAs (lncRNAs) play roles in regulating cellular functions. High-throughput sequencing analysis identified a new lncRNA, termed LAMTOR5-AS1, the expression of which was much higher in the chemosensitive osteosarcoma (OS) cell
Externí odkaz:
https://doaj.org/article/b0492a48926b4bffa3f4d12033f6c756
A New Functional Gene, Zinc Finger Protein 485 (ZNF485), is Involved in Bladder Cancer Proliferation
Autor:
Yiao Tan, Fangfang Zhao, Shuhan Liu, Tao Huang, Chunbao Zang, Dan Sha, Lingsuo Kong, Fangfang Ge, Dabing Huang, Youguang Pu
Publikováno v:
Bladder Cancer. 8:165-177
BACKGROUND: Bladder cancer is the second most common urological cancer worldwide, with low early diagnosis and high mortality. The limited progress in diagnostics and treatment greatly impedes the survival of bladder cancer patients. OBJECTIVE: Poten
Publikováno v:
World Journal of Urology. 40:973-982
The present study introduces a modified surgical procedure, extraperitoneal laparoscopic simple prostatectomy (LSP) with urethra preservation using urethral initiation as the entry point, and evaluates its feasibility, safety, and efficacy in the tre
Autor:
Dabing Huang, Yiao Tan, Fangfang Zhao, Chunbao Zang, Shuhan Liu, Tao Huang, Lingsuo Kong, Fangfang Ge, Youguang Pu
Publikováno v:
Clinical Oncology and Research. :1-8
Objectives: Bladder cancer is the second most common urological cancer worldwide with low early diagnosis and high mortality. The limited progress on the diagnostics and treatment largely impedes the survival of bladder cancer patients. Methods: Pote
Autor:
Youguang Pu, Lingsuo Kong, Fei Gao, Fangfang Zhao, Ran Xia, Cifeng Cai, Yiao Tan, Dabing Huang, Zhenyu Li, Fangfang Ge, Ran Wei, Chunbao Zang
The mRNA post-modifications, such as N6-methyladenosine (m6A) modification, have been found to play a role in a variety of cancers. The impact of m6A modification in esophageal cancer (EC), which is one of the most frequently occurred malignancies wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e68b7d23d6d0366368390296e7f5d00c
https://doi.org/10.21203/rs.3.rs-1556752/v1
https://doi.org/10.21203/rs.3.rs-1556752/v1
Autor:
Fangfang Zhao, Chunbao Zang, Fengmei Chao, Hui Deng, Youguang Pu, Ran Xia, Minghua Xie, Lingsuo Kong, Yiao Tan, Fangfang Ge, Shanbao Cai, Dabing Huang, Yueyin Pan, Cifeng Cai
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 12, Pp 1-15 (2021)
Cell Death and Disease, Vol 12, Iss 12, Pp 1-15 (2021)
Long-noncoding RNAs (lncRNAs) play roles in regulating cellular functions. High-throughput sequencing analysis identified a new lncRNA, termed LAMTOR5-AS1, the expression of which was much higher in the chemosensitive osteosarcoma (OS) cell line G-29
Autor:
Fangfang Zhao, Fangfang Ge, Minghua Xie, Zhenyu Li, Chunbao Zang, Lingsuo Kong, Youguang Pu, Xucai Zheng, Yiao Tan
Publikováno v:
Clinicalexperimental metastasis. 39(4)
N6-methyladenosine (m6A) is the most prevalent and internal modification that occurs in the messenger RNAs of eukaryotes. However, knowledge of the impact of these modifications on gene expression regulation remains limited. By using the in vitro MeR
Background N6-methyladenosine (m6A) is the most abundant modification in eukaryotic messenger RNAs (mRNAs), and plays important roles in many bioprocesses. However, its functions in esophageal cancer (ES) remain elusive. Methods Methylated RNA immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e9f4ebee6156268762ed1a5efbffd8
https://doi.org/10.21203/rs.3.rs-589523/v1
https://doi.org/10.21203/rs.3.rs-589523/v1
Publikováno v:
Medical Science Monitor; 2/19/2019, Vol. 25, p1323-1335, 13p
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Chemoresistance is a main limitation in chemotherapy for therapeutic cancer. MicroRNA (miRNA) has been indicated in the progression and tumorigenesis of many types of cancer, but the effect of miR-34b-3p in bladder cancer (BCa) cells is st